Randox – Nutritional Status
Randox are dedicated to improving health worldwide, throughout the month of July we hope to highlight how the Randox clinical product range can assess an individual’s nutritional status both accurately and swiftly allowing the necessary steps to be taken in order to improve nutritional status. Nutritional status is influenced by diet, the levels of nutrients in the body and the body’s ability to maintain normal levels of metabolic integrity. Assessing nutritional status will generally indicate if an individual is eating the correct variety and quantity of nutrients. The Randox portfolio comprises a wide range of products to combat nutritional status issues including the RX series range of biochemistry analysers, diagnostic reagents such as zinc, copper & lipase and an extensive QC range catering for nutritional status testing in both liquid & lyophilised formats.
Nutritional Status: Reagents
Randox Reagents have the highest quality reagents on the market and a test menu comprising of over 113 assays. Unique to Randox is the copper and zinc assays that hold equal importance in the diagnosis of kidney and liver damage.
The Randox zinc assay can be used to measure levels of zinc in a patient’s urine providing insight into the levels of zinc in the body. The Randox copper assay is used to measure the levels of copper in the blood in order to determine copper toxicity. Combining these Randox assays can aid in identifying the cause of liver damage in a patient, leading to correct treatment and recovery.
Nutritional Status: RX series
The RX series range offers the most comprehensive testing profile for assessing nutritional status to identify any nutritional deficiencies or any other nutritional issues within an individual. The world famed RX series test menu possesses the most extensive nutritional status testing panel available to give an expansive picture of an individual’s nutritional status. The RX series zinc test can identify a zinc deficiency in an individual which is often a result of a low dietary intake and can lead to many problems including impaired immune & cognitive functions, kidney disease and diabetes. To view the full RX series test menu click here.
Nutritional Status: Quality Control
The Randox Acusera Liquid Chemistry Premium Plus control is designed for use in the routine monitoring of reproducibility and is the most comprehensive chemistry control available. As a true third party control it is suitable for use with all major instruments and covers over 100 parameters including routine chemistries, immunoassays, lipids, cardiac markers, proteins, therapeutic drugs and electrophoresis effective consolidation and significant cost savings are guaranteed.
Nutritional Status: RIQAS
The RIQAS General Clinical Chemistry EQA programme is designed to monitor the performance of up to 52 parameters covering routine chemistries, lipids, hormones and trace metals. Three flexible, cost effective programme options allow you to choose the correct challenge that is right for your lab. Bi-weekly, online reporting with reports returned within 72 hours allows corrective action to be taken sooner, avoiding dangerous misdiagnoses.
Randox are dedicated to improving health worldwide, Throughout the month of June we hope to highlight how the Randox clinical product range can ensure accurate and swift diagnosis and by doing so improving women’s health by allowing for the necessary steps to be taken post diagnoses. A common held misconception is that breast cancer is the biggest threat to a women’s health however the biggest health risk to a woman statistically is heart disease which accounts for roughly 27% of female death. The Randox clinical product range offers a wide range of products to combat heart issues including the RX series extensive cardiac testing panel, reagents such as H-FABP, Adiponectin an TxB Cardio and an extensive cardiac QC range available in both liquid & lyophilised format.
Women's Health: Reagents
Randox Reagents have the highest quality reagents on the market and a test menu comprising of over 118 assays covering over 100 disease markers. Several of these reagents will play a key role in diagnosis in woman such as Randox’s Lipoprotein (a) – Lp(a) test, The Randox Lp(a) offers swift and accurate diagnosis of elevated circulation Lp(a) levels which is significant for woman as women have an increased risk of CVD due to elevated levels of Lp(a). Several traditional CVD risk markers, including elevated LDL may be absent in some women, elevated Lp(a) levels may identify women at high risk of developing CVD.
Women's Health: RX series
The RX series range of clinical chemistry analysers offers the most comprehensive testing profile for assessing health in males and females. Urinary tract infections are more commonly found in women and the RX series extensive renal function panel will provide clarity in terms of a woman’s urological health by testing for 19 separate analytes, including microalbumin. The RX series microalbumin test can detect very low levels of albumin in urine and if albumin is detected it can be an indicator of kidney injury and can result in irreversible damage. To view the full RX series test menu click here.
Women's Health: Quality Control
The Randox Acusera Maternal Screening quality control is the only commercially available control which covers all six analytes used during first and second trimester screening of Down’s syndrome and Spina Bifida. Instrument specific target values and ranges are provided for AFP, Inhibin A, PAPP-A, β hCG, Total hCG and Unconjugated Estriol. The inclusion of PAPP-A and Inhibin A eliminates the need to purchase additional controls at extra expense.
Women's Health: RIQAS
The RIQAS Maternal Screening EQA programme is designed to monitor the performance of screening tests used during the first and second trimester of pregnancy to assess the risk of Down’s syndrome, Spina Bifida and Trisomy 18. 100% human serum ensures commutability while the lyophilised material allows for enhanced stability. Monthly reporting allows laboratories to become aware of issues and remedy them early.
Neonatal screening is vital for the overall health of newborn babies. Although it is not a mandatory procedure it is highly recommended to detect infections and diseases that can have devastating consequences if not diagnosed soon after birth. Randox’s range of neonatal reagents include CRP, Bilirubin and Complement C4 that are essential in the detection of neonatal lupus and jaundice; which if left undetected can lead to sickle cell anaemia, rubella and even syphilis. Armed with these specific and high quality reagents and Randox Quality Control material ensures not only the early detection of such diseases but also the accuracy and reliability of the laboratory test results that can help to ensure that your baby gets the best start in life.
Neonatal Health: Reagents
Randox Reagents have the highest quality reagents on the market and a test menu comprising of over 118 assays covering over 100 disease markers. Our specific reagents for neonatal health include, G-6-PDH, IgE, Bilirubin, Copper, Complement C4 & C3, IgA , CRP and CRP full range. With flexible pack sizes and a comprehensive list of analyser applications available, you are sure to find what you are looking for.
Neonatal Health: RX series
Randox has developed the RX series of clinical chemistry analysers for superior semi-automated and fully automated testing. The RX series extensive dedicated test menu goes beyond routine testing and has many unique and high-performance tests available. Our range of tests covers several parameters to assess neonatal health.
Neonatal Health: Quality Control
Randox Liquid Bilirubin Control provides a true third party solution for the measurement of bilirubin. Designed to deliver unbiased and independent results, it ensures your instrument is accurate and reliable when testing real patient samples. An elevated bilirubin control is also available to monitor accuracy at higher levels enabling early medical intervention when it matters.
Neonatal Health: RIQAS
RIQAS is the largest international external quality assessment scheme with 45,000 participants worldwide. With 33 comprehensive EQA programmes and world renowned consolidation, it reduces the number of individual programmes required. RIQAS programmes are available to compliment neonatal health tests.